Purchases and Sales Made in Q2 2023 in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS) during Q2 2023. The information is specifically focused on institutions that hold shares of Keros Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-165K- 9.81% |
$6.14M - $8.4M
|
1.51M
$17.3M
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-173K- 53.12% |
$6.45M - $8.84M
|
153K
$1.74M
|
|
|
Aug 14, 2023
Q2 2023
|
First Light Asset Management, LLC
Edina, MN |
SELL
|
- |
-177K- 29.82% |
$6.6M - $9.04M
|
417K
$4.76M
|
|
|
Aug 14, 2023
Q2 2023
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-246K- 33.07% |
$9.15M - $12.5M
|
497K
$5.67M
|